Baird Medical Investment Holdings (BDMDW) Shares Outstanding (Diluted Average) (2024 - 2025)
Baird Medical Investment Holdings' quarterly Shares Outstanding (Diluted Average) came in at $430.0 in Q2 2025, up 152.94% year-on-year from $170.0 in Q2 2024, and up 152.94% quarter-over-quarter from $170.0 in Q2 2024.
Baird Medical Investment Holdings has reported Shares Outstanding (Diluted Average) for 2 years, with the latest figure at $430.0 in Q2 2025.
- For the quarter ending Q2 2025, Shares Outstanding (Diluted Average) rose 152.94% year-over-year to $430.0; the trailing twelve-month figure through Jun 2025 stood at $430.0 (up 152.94% YoY), and the FY2022 full-year result was $25.6 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) for Q2 2025 stood at $430.0, up from $170.0 in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $430.0 in Q2 2025, with the low at $170.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Baird Medical Investment Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 430.00 |
| Jun 30, 2024 | 170.00 |